Nije utvr?ena bezbednost i efikasnost primene filgrastima kod pacijenata sa mijelodisplasti?nim sindromom ili hroni?nom mijeloidnom leukemijom.Since scientific trials are carried out under commonly varying conditions, adverse response prices noticed within the scientific trials of the drug cannot be instantly in comparison with fees inside the scie